Intermediate filament (IF) proteins utilize central α-helical domains to generate polymeric fibers intermediate in size between actin microfilaments and microtubules. The regions flanking the central structural domains have diverged greatly to permit IF proteins to adopt specialized functions. Keratins represent the largest two groups of IF proteins. Most keratins serve structural functions in hair or epidermis. Intracellular epidermal keratins also provide strength to epithelial sheets. The intracellular type I keratins and other IF proteins are cleaved by caspases during apoptosis to ensure the disposal of the relatively insoluble cellular components. However, recent studies have also revealed an unexpected protective role for keratin 8 during TNF and Fas mediated apoptosis. Evidence for possible functions of keratins both upstream and downstream of apoptotic signaling are considered.
Three filamentous systems make up the cytoskeleton of cells. These are microfilaments, microtubules and the intermediate filaments. Sixty-five homologous proteins with the ability to form 10 nm filaments define the intermediate filament family in humans.1,2 They likely arose by mutation of an ancestral nuclear lamin gene3 and are restricted in expression to metazoans.4 Individual IFs have diverged and specialized their N-terminal and C-terminal domains that flank the α-helical central region necessary for filamentous polymerization. The proteins are divided into at least five groups as shown in Table 1. The type I and type II keratins are the largest subgroups of the intermediate filament family. The keratins polymerize as obligate heteropolymers of individual type I and type II proteins. The keratins are further subdivided into epithelial and hair related keratins. Type III IF proteins are represented by vimentin, glial fibrillary acidic protein, desmin and peripherin. Type IV IF proteins include the three forms of neurofilament proteins, α-internexin, syncollin, nestin and synemin and the type V IF proteins represent the three nuclear lamins.
Investigations of the functions of specific intermediate filament proteins and the identification of mutant IF proteins involved in human genetic diseases have demonstrated that many IF proteins function to provide mechanical strength to cells and tissues. This is clearly demonstrated in mammalian skin where mutations or the absence of specific epidermal keratins causes epidermal fragility resulting in blistering skin diseases5,6,7 and alterations in the mechanical properties of filaments.8 Similarly, muscle mechanical defects are evident in the absence of desmin.9 In addition, A2 and A3 IF proteins of Caenorhabditis elegans are necessary for locomotion.4 The keratins associated with hair are uniquely specialized for stability reinforced by extensive extracellular disulfide bridging. The specialized keratins of the outer epidermis (K1, K2, K9, K10) are distinguished by tail domains greatly enriched in glycine and by the lack of caspase cleavage sites within the type I extracellular keratins (K9, K10). These keratins contribute to the structural integrity essential for the barrier function of the skin. Intracellular epithelial keratins such as K5 and K14 crossbridge desmosomal junctions and thus provide structural continuity with the edges of epithelial cells. Individual keratins bind to the desmoplakin component of desmosomes with varying affinity and structural requirements.10,11 Additional adapter proteins also contribute to the association of IF with desmosomes.12 Keratins and E-cadherin are two defining characteristics of epithelial cells. Many simple epithelial cells are particularly sensitive to apoptosis when detached from extracellular matrix and neighboring cells in a process termed anoikis.13,14 A possible role of keratins in anoikis remains to be investigated. Multiple excellent reviews concerning the structure, dynamics and function of intermediate filaments are available.2,5,15,16,17,18,19,20 Further discussion here will focus on the possible roles of keratins in apoptosis.
K8 and K18
K8 and K18 are expressed in simple, or predominately single layered, internal epithelia. Several characteristics of K8 and K18 distinguish them from other members of the type I and II keratins. First, they are the first IF proteins to be expressed during mammalian development being associated with the differentiation to the trophectodermal layer of the blastocyst. However, the human epiblast, unlike the mouse inner cell mass, is an epithelium and expresses K8 and K18. In addition to the unique genes coding for human K8 and K18, each is represented by 35 and 62 processed pseudogenes respectively. These are distributed over many chromosomes.1,21 The large number of processed pseudogenes for K8 and K18 may reflect their expression in the human epiblast which provides a germ line target for retroviral reverse transcription.16 The smaller number of K8 and K18 pseudogenes found in mice21,22 is consistent with the difference in expression of these genes during early development. K18 is also the only type I keratin found within the type II keratin multigene locus found on human chromosome 12. The other type I keratins are found on chromosome 17. The genes for K8 and K18 are adjacent to each other and at the distal end of the Krt1 locus.
Another distinguishing characteristic of K8 and K18 is their common and persistent expression in carcinomas. Other keratins that are expressed in the tissue of origin of carcinomas tend to be more sporadically expressed or lost during the progression of the tumor. K8, K18 and K19 have proved to be useful carcinoma markers.
While keratins are promiscuous in their ability to heterpolymerize from different type I and II proteins in vitro,23,24 preferential assembly of certain keratin pairs in vivo has been revealed by gene knockout experiments. Thus the removal of K18 results in the loss of K7 as well as K8 protein in intestine.25 In the absence of a complementary partner K8 and K18 are normally degraded rapidly, although K8 is degraded less quickly than K18 in some cells.26 In K18 null animals, aggregates of precipitated K8 residue, known as Mallory bodies, are found in the livers of old animals. Thus the degradation of K8 may not necessarily be complete, at least under some pathological conditions.25
Gene targeting experiments have demonstrated that K8 is important for development because K8 deficient embryos die at E12.5.27 However, the viability of K8 deficient mice is dependent on the genetic background.28 In an FVB/N genetic background approximately 50% of the expected number of K8 deficient embryos are born. By contrast, the knockout of K18 or K19 does not alter viability.25,29 However, K18, K19 compound homozygote null embryos die at about 9 days of development.30 Thus K18 deficiency is compensated by K19 and vice versa (Table 2). K8 deficiency is also compensated to some degree by K19 because K8, K19 compound homozygote null embryos die earlier than K8 null embryos.29 The protective effect of K19 is likely due to low levels of K7, expressed in late trophoblast derivatives. This interpretation of K8, K18 and K19 knockouts is summarized in Table 2. However, the absence of all keratins (and very likely all IF) in K18, K19 compound homozygotes still permits keratin deficient blastocysts to implant, invade the uterine environment and develop for 9 days. If K8 and K18 primarily provide mechanical strength, it is perhaps surprising that development can proceed during trophectoderm expansion, implantation, and invasion. Furthermore, no abnormalities of parietal or visceral yolk sac development were detected during the differentiation of K8 deficient ES cells in vitro.31 Thus K8 is not necessary for the appearance or function of polarized epithelial yolk sac cells or the initial trophoblast derivatives. Other cytoskeletal elements may provide sufficient strength to implanting embryos until day 9 of development. However, the postimplantation failure of trophoblast derivatives may reflect additional functions for simple epithelial keratins.
K8 and K18 associated disease
The incomplete penetrance of embryonic lethality of K8 null mice has permitted the evaluation of the importance of K8 in adult mice. Adult K8 null mice in the semipermissive FVB/N background develop a mild hepatitis and a more dramatic inflammatory bowel disease by about 6 months of age.28 This condition is similar to that seen in mice without the T cell receptor α32 or the IL-233 and IL-1034 cytokines. In addition, K8 null adults were found to be particularly sensitive to pentobarbital anesthesia, partial hepatectomy35 and to liver toxicity induced by griseofulvin, 3,5-diethoxycarbonyl-1, 4-dihydrocollidine36 acetaminophen37 or the phosphatase inhibitor microcystin-LR.38 In the case of griseofulvin treatment, which models the formation of Mallory bodies in alcoholic liver disease, the use of K8 null animals revealed that Mallory body formation was dependent on K8. However, K8 null animals developed liver disease even in the absence of Mallory bodies.36 Thus these dense aggregates of cross-linked and modified K8/K18 are not the causative agent of subsequent liver damage. An important role for K8/K18 in resistance to liver toxicity is reinforced by the increased sensitivity of transgenic mice which overexpress mutant forms of K18 to griseofulvin, acetaminophen and microcystin-LR.37,39,40 Recently, mutations of K8 in humans have been found to be associated with cryptogenic liver disease41 and inflammatory bowel disease (Birgit Lane, personal communication). In the case of crytogenic liver disease, two mutations of K8 have been identified. One changes a tyrosine at position 53 to a histidine (Y53H). The second changes a conserved glycine at position 61 to a cysteine (G61C). One consequence of the G61C is disulfide bridging of K8, apparently to itself. Both mutations appear to alter the stability of K8/K18 filaments when cells are stressed but not under normal growth conditions. Together, the mouse and human diseases associated with K8 mutations indicate an important role in resistance to liver toxicity and inflammatory bowel disease. The mechanism of the protective effects of K8/K18 remains to be determined.
K8 and TNF sensitivity
A recent observation has implicated K8 and K18 in resistance to apoptosis induced by TNF family receptors. Several epithelial cell lines deficient in K8/K18 IF are more sensitive to apoptosis induced by the combination of TNF and cycloheximide than their control counterparts.42 This resistance to TNF was correlated with the ability of K8 but not K18 to bind to the cytoplasmic domain of TNFr2 and the lymphotoxin-β receptor (LTβR) but not TNFr1 or Fas. Co-localization of TNFr2 and K8/K18 was detected at the periphery of cells. In addition, treatment of either K8 or K18 null animals with concanavalin A (ConA) showed that the hepatocytes of both types of keratin deficient animals were more sensitive to lymphocyte initiated apoptosis. K8 and K18 are the only IF proteins expressed in hepatocytes. Thus gene targeting of either gene results in the absence of hepatocyte IF. ConA induced hepatitis acts through circulating blood elements and involves both Fas and TNF.43,44,45 Increased levels of both TNF and Fas ligand are found in the livers of mice treated with ConA. The similar response of both K8 and K18 null animals to ConA was of particular interest because K18 null animals are phenotypically normal and do not develop the spontaneous mild hepatitis found in K8 null animals. The colonic hyperplasia of the K8 null animals may also reflect the involvement of the immune system. It is interesting that trophoblast derivatives are normally resistant to TNF induced apoptosis.46,47 It is possible that TNF sensitivity may be involved in the trophoblastic defects found in null K8 and K8, K19 and K18, K19 compound null animals.
K8 and Fas
Very recently, a similar role for K8 in protection from Fas mediated apoptosis of hepatocytes has been discovered.48 Explanted hepatocytes from K8 deficient mice are particularly sensitive to activating Fas antibody but not TNF or TRAIL. Furthermore, the increased sensitivity to Fas activating antibody was correlated with an increase in the fraction of cellular Fas on the cell surface. Total Fas levels in K8 null and wild-type hepatocytes appear similar. The increased sensitivity of K8 null animals to activating Fas antibody was found only at a moderate dose of antibody. Microtubule dissociating drugs helped protect hepatocytes from subsequent Fas antibody challenge. K8/K18 may be involved in the trafficking of Fas from the Golgi to the apical surface of polarized epithelia.
Increased Fas on the cell surface of K8 null hepatocytes may predispose them to apoptosis because over expression of death receptors can trigger the apoptotic cascade even in the absence of ligand. However, TNF is key for liver growth and regeneration as well as an apoptotic stimulus.49 Perhaps K8 hepatocytes are presensitized to Fas stimulation by previous exposure to TNF. It will be interesting to determine if K18 null mice also express elevated levels of hepatocyte surface Fas and to analyze the effects of TNF and Fas deficiencies on K8 null embryonic lethality.
The association of K8/K18 with death receptor family function may be related to earlier implications of K8/K18 with drug resistance in several cell lines.50,51 Some K8/K18 deficient cell lines are more sensitive to DNA damaging agents such as mitoxantrone, doxorubicin, melphalan, bleomycin, and mitomycin C than the controls that were engineered to express keratin. These drugs have been shown to induce surface Fas expression through a p53 dependent process in multiple cancer cells.52 Increased Fas expression sensitizes cells to FasL stimulated killing. Chemotherapeutic drug treatment sensitizes multiple cancer cell lines to either Fas or Trail killing.53 While several observations indicate that killing of cancer cells by DNA damaging agents is not exclusively dependent on Fas,54 Fas or other death receptors may contribute to the cellular damage. The role of keratin IFs in resistance to some drug induced apoptosis, may be linked to death receptors.
K8 and K18 have now been convincingly connected to resistance to multiple kinds of stress.15,19 This evidence includes the association of HSP70 with K18;55 the increased sensitivity of K8 null mice and K18 dominant negative transgenic mice to the toxicity of acetaminophen,37 microcystin-LR38 and griseofulvin36 and the increased sensitivity of K8 null mice to pentobarbital and liver perfusion.35 While the correlation of various forms of stress with K8/K18 filament phosphorylation is well established, the mechanism by which these keratins confer resistance or protection is less obvious. One potential common thread to many types of stress is TNF family involvement.
However, one potential contradiction to the function of K8/K18 in moderating TNF family ligand induced pathology is the surprising lack of protective effect of either K8 or K18 on experimentally induced pancreatitis.56 TNF is reported to contribute to the severity of the experimental disease.57 However, TNF may play a secondary role in the pancreatitis models and a more direct role in several liver toxicity models.
How might K8/K18 moderate TNF and Fas induced apoptosis?
Both TNF and FasL normally induce apoptotic signaling by the engagement of the cognate receptors. However, increased surface expression of receptor can also initiate signaling. The increased sensitivity of K8 null hepatocytes to activating Fas antibody has been suggested to be a reflection of the increased proportion of Fas expressed at the cell surface. This would imply that K8/K18 filaments might specifically moderate the transport of Fas to the cell surface. This suggestion is of particular interest in light of the recent identification of abnormalities in the distribution of apical surface markers in both the small intestine and liver of K8 null animals.58 In the small intestine of K8 null animals, regional specific differences in the expression of syntaxin-3, intestinal alkaline phosphatase and CFTR chloride channel proteins were found. Given the rapid turnover of intestinal cells, these regional differences on the villi may reflect alterations in the turnover of the proteins. Syntaxin-3 is a key element of the SNARE machinery involved in specific vesicular transport. Interestingly, sytaxin-3 is co-localized with vimentin filaments in fibroblasts and Hela cells59 but is not found associated with the K18 filaments of Hela cells. The mechanism by which keratin filaments might influence vesicular trafficking of specific surface molecules remains to be elucidated. However, the recently appreciated dynamic properties of IF including rapid intracellular movement60 facilitates consideration of many possibilities.
Interference with the transport of TNFr1 from the Golgi to the cell surface has been shown to be a mechanism of inhibition of TNF induced apoptosis in poliovirus infected cells.61 This function would place K8/K18 upstream of TNFr or Fas receptor signaling. Alternatively, K8 may play a role downstream of TNFr signaling by moderating the signaling from receptors. Indirect evidence of IF involvement in signaling includes the increased NF-κB and Jnk activation found in keratin deficient endodermal cells in response to TNF,42 the binding of 14-3-3 protein to K18 in a phosphorylation dependent manner,62 and MAP kinase phosphorylation of IF proteins.63 K8 is capable of binding the cytoplasmic domain of TNFr2. However, signaling through TNFr2 is significantly different from TNFr1, as TNFr2 has no death effector domain. One example of an indirect mechanism of influencing TNF signaling is the induction of TNF on the cell surface by TNFr2 signaling which then contributes to apoptosis.64
Very recently Inagaki and colleagues65 described an alternative and likely key mechanism by which keratin attenuates TNF induced death. Residues 77–128 of K18 and K14 both mediate an association with the C-terminal portion of TNFR1-associated death domain protein (TRADD). This association with a key adapter molecule was demonstrated biochemically by co-assembly, co-immunoprecipitation analysis, and by immunofluorescent localization of both endogenous and exogenous TRADD and K18. Importantly, this investigation provides evidence for the competition of ligand activated TNFR1 and keratin for TRADD that dissociates from keratin and associates with ligand bound TNFR1 to form a signaling complex that activates caspase 8. This report provides the best present explanation of the protective effect of K8/K18. The very interesting control of the association of TRADD with keratins will likely be an important focus of future investigation.
Intermediate filament proteins are cleaved by caspases during apoptosis
Nearly 30 years ago, Bjorklund developed an antibody test for tissue polypeptide antigen (TPA) that was found in the serum of cancer patients. The nature of this circulating antigen remained obscure in spite of significant use of the tumor marker, until 1984, when the antigen(s) was identified as a complex of keratin 8, 18 and 19 fragments.66 This discovery helped explain the correlation of TPA with carcinoma status because most carcinoma continued to express epithelial keratin intermediate filament proteins K8, K18 and K19.67 However, the origin of soluble fragments of insoluble keratin was still a puzzle. In 1997, Caulin et al. demonstrated that K18 but not K8 was a substrate for caspase digestion during the course of epithelial cell apoptosis.68 Caspases 3, 6 and 7 were all capable of cleaving after the aspartate 238 (D238) and mutation of the DEVD238 sequence rendered this site resistant to cleavage both in vitro and in vivo.68,69 However, the K18 internal cleavage site is utilized in apoptotic MCF-7 cells which are deficient in caspase 3.70 Thus caspase 3 is not essential for K18 cleavage at D238. A second cleavage site nearer the C-terminal end was deduced on the basis of a ten residue, monoclonal antibody epitope terminating with a potential caspase cleavage site, DALD,397 that rendered antibody binding dependent on apoptotic cleavage of K18.71 The identification of D397 as the second caspase cleavage site of K18 was confirmed by mutagenesis.72
The first intermediate filament protein to be identified as a caspase substrate was the nuclear lamin A.73,74 The internal cleavage site of lamin A is identical to that found in K18. This cleavage site of K18 and other IF proteins is found within the L1-2 linker region between two conserved, central, alpha helical domains (Figure 1).75 None of the type II keratins have similar potential cleavage sites. Simple alignment of other IF proteins lead to the prediction that other type I keratins and vimentin, desmin and NF-M would likely be caspase substrates. Caspase cleavage at the L1-2 linker region has been confirmed for K14, K17, K19, and vimentin.72,76 The L1-2 caspase cleavage site of multiple type I keratins is of particular interest because mutations of the caspase recognition site have been found in K14 of patients with epidermolysis bullosa simplex, a genetic blistering skin disease. However, a careful analysis of four spontaneous mutations within the context of K14 revealed that only the mutation of the required aspartate (VEVD or VEMD) prevented cleavage of K14 during apoptosis.72 Confirmation of the cleavage of the wt sequence VEMD/A of K14 suggests that other type I keratins, K12–17, desmin and neurofilament-L may also be caspase substrates.
Consequences of caspase digestion of IF during apoptosis
The orderly packaging and disposal of cellular contents during cell death may be important to limit inflammatory reaction. The cleavage of IF during apoptosis may reflect the programmed disposal of relatively insoluble structural proteins. The engagement of Fas with FasL, or activating antibody results in the formation of a signaling complex involving proteins with death effector domains such as FADD and the subsequent activation of caspase 8. Caspase 8 translocates from either a membrane or mitochondrial location to plectin, an abundant cytoskeletal scaffolding protein which binds all three cytoskeletal fibers, actin, intermediate filaments and microtubules. The subsequent cleavage of plectin by caspase 8 results in a reorganization of the microfilament system.70 The early cleavage of plectin appears not to affect intermediate filament organization. Soon after an apoptotic challenge K8/K18 filaments are hyperphosphorylated and collapse to punctate inclusions of variable size (Figure 2). Similar K18 aggregations have been observed in some epithelial cells not undergoing apoptosis77 and may reflect the consequences of keratin phosphorylation.63 During TRAIL induced apoptosis, activated caspase 3 co-localizes with similar, though larger aggregates late in the process of death.78 This organization into dense aggregates without a limiting membrane appears to contain most of the activated caspase 3 and the K18 that has been cleaved at position D397. The status of the VEVD238 cleavage site in such aggregates is not known. If the association of active caspase 3 with these aggregates is strictly dependent on the presence of K18, it is possible that keratins may provide some protection against caspase 3 digestion by limiting the availability of active caspase 3.
The hyperphosphorylation of K18 in cells treated with okadaic acid, a phosphatase inhibitor, was found to render K18 resistant to caspase digestion at D238 but not D397.72 This is an interesting result in light of the rapid phosphorylation of K18 on serine 53 after apoptosis initiation.68,69,79 The reorganization of K18 filaments in apoptotic cells is associated with the cleavage of K18 at D397, K18 phosphorylation at S53, and the association of active caspase 3 with the K18 granules. However, it is not clear whether the reorganization of keratin filaments is caused by its phosphorylation alone, its cleavage or even an association with other proteins within the cells. Dissection of the roles of K18 phosphorylation, its association with caspase 3 and caspase cleavage of K18 may reveal new ways to regulate caspase activity.
While the initial observations linking intermediate filaments and apoptosis involved lamins and keratins, other IF proteins may also function during the process. For example, vimentin is a caspase substrate.76,80 Furthermore, the forced expression of the N-terminal caspase digestion product of vimentin as a GFP fusion protein has been reported to induce caspase dependent apoptosis.76 This effect is suggested to amplify the death signal. However, the effect has only been reported with the GFP fusion protein and the natural N-terminal caspase product of vimentin has not been detected in apoptotic cells suggesting that it may be further degraded rapidly. Additional investigation should reveal whether the subtle phenotypes of the vimentin knockout81,82 may be supplemented by a functional role in apoptosis.
In summary, simple epithelial keratins have been implicated in resistance to drug toxicity, hepatic stress and inflammatory bowel disease. Recent connections of death receptor involvement with epithelial apoptosis in both cell lines and mouse models should stimulate further advances in understanding the possible functions of programmed cell death.
glial fibrillar acidic protein
tumor necrosis factor
TNF receptor 1
TNF receptor 2
tissue polypeptide antigen
green fluorescent protein
Hesse M, Magin TM, Weber K . 2001 Genes for intermediate filament proteins and the draft sequence of the human genome: Novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18 J. Cell Sci. 114: 2569–2575
Fuchs E, Weber K . 1994 Intermediate Filaments: structure, dynamics, function, and disease Ann. Rev. Biochem. 63: 345–382
Weber K, Plessmann U, Ulrich W . 1989 Cytoplasmic intermediate filament proteins of invertebrates are closer to nuclear lamins than are vertebrate intermediate filament proteins; sequence characterization of two muscle proteins of a nematode EMBO J. 8: 3221–3227
Karabinos A, Schmidt H, Harborth J, Schnabel R, Weber K . 2001 Essential roles for four cytoplasmic intermediate filament proteins in Caenorhabditis elegans development Proc. Natl. Acad. Sci. USA 98: 7863–7868
Fuchs E, Cleveland DW . 1998 A structural scaffolding of intermediate filaments in health and disease Science 279: 514–519
Fuchs E, Chan YM, Paller AS, Yu QC . 1994 Cracks in the foundation: keratin filaments and genetic disease Trends Cell Biol. 4: 321–326
Fuchs E . 1997 Of mice and men: genetic disorders of the cytoskeleton Mol. Biol. Cell 8: 189–203
Ma LL, Yamada S, Wirtz D, Coulombe PA . 2001 A ‘‘hot-spot’’ mutation alters the mechanical properties of keratin filament networks Nat. Cell Biol. 3: 503–506
Li Z, Colucci-Guyon E, Pincon-Raymond M, Merickskay M, Pournin S, Paulin D, Babinet C . 1996 Cardiovascular lesions and skeletal myopathy in mice lacking desmin Dev. Biol. 175: 362–366
Meng J-J, Bornslaeger EA, Green KJ, Steinert PM, Ip W . 1997 Two-hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type-specific intermediate filaments J. Biol. Chem. 272: 21495–21503
Smith EA, Fuchs E . 1998 Defining the interactions between intermediate filaments and desmosomes J. Cell Biol. 141: 1229–1241
Ouyang P, Sugrue SP . 1996 Characterization of pinin, a novel protein associated with the desmosome-intermediate filament complex J. Cell Biol. 135: 1027–1042
Frisch SM, Francis H . 1994 Disruption of epithelial cell-matrix interactions induces apoptosis J. Cell Biol. 124: 619–626
Frisch SM, Screaton RA . 2001 Anoikis mechanisms Curr. Opin. Cell Biol. 13: 555–562
Coulombe PA, Omary MB . 2002 ‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments Curr. Opin. Cell Biol. in press
Oshima RG, Baribault H, Caulin C . 1996 Oncogenic regulation and function of keratin 8 and 18 Cancer Metastasis Rev. 15: 445–471
Chou YH, Goldman RD . 2000 Intermediate filaments on the move J. Cell Biol. 150: F101–F106
Coulombe PA, Bousquet O, Ma L, Yamada S, Wirtz D . 2000 The ‘ins’ and ‘outs’ of intermediate filament organization Trends Cell Biol. 10: 420–428
Ku N-O, Zhou X, Toivola DM, Omary MB . 1999 The cytoskeleton of digestive epithelia in health and disease Amer. J. Physiol. 277: 1108–1137
Herrmann H, Aebi U . 2000 Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics Curr. Opin. Cell Biol. 12: 79–90
Oshima RG, Trevor K, Shevinsky LH, Ryder OA, Cecena G . 1988 Identification of the gene coding for the endothelial B murine cytokeratin and its methylated, stable inactive state in mouse nonepithelial cells Genes Dev. 2: 505–516
Vasseur M, Duprey P, Brulet P, Jacob F . 1985 One gene and one pseudogene for the cytokeratin endothelial A Proc. Natl. Acad. Sci. USA 82: 1155–1159
Hatzfeld M, Franke WW . 1985 Pair formation and promiscuity of cytokeratins: formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides J. Cell Biol. 101: 1826–1841
Karabinos A, Riemer D, Erber A, Weber K . 1998 Homologues of vertebrate type I, II and III intermediate filament (IF) proteins in an invertebrate: the IF multigene family of the cephalochordate Branchiostoma FEBS Lett. 437: 15–18
Magin TM, Schroder R, Leitgeb S, Wanninger F, Zatloukal K, Grund C, Melton DW . 1998 Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates J. Cell Biol. 140: 1441–1451
Kulesh DA, Cecena G, Darmon YM, Vasseur M, Oshima RG . 1989 Post-translational regulation of keratins: degradation of unpolymerized mouse and human keratins 18 and 8 Mol. Cell Biol. 9: 1553–1565
Baribault H, Price J, Miyai K, Oshima RG . 1993 Mid-gestational lethality in mice lacking keratin 8 Genes Dev. 7: 1191–1202
Baribault H, Penner J, Iozzo RV, Wilson-Heiner M . 1994 Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice Genes Dev. 8: 2964–2973
Tamai Y, Ishikawa T-O, Bosl MR, Mori M, Nozaki M, Baribault H, Oshima RG, Taketo MM . 2000 Cytokeratins 8 and 19 in the mouse placental development J. Cell Biol. 151: 563–572
Hesse M, Franz T, Tamai Y, Taketo MM, Magin TM . 2000 Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality EMBO J. 19: 5060–5070
Baribault H, Oshima RG . 1991 Polarized and functional epithelia can form after the targeted inactivation of both mouse keratin 8 alleles J. Cell Biol. 115: 1675–1684
Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa ST . 1993 Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice Cell 75: 275–282
Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I . 1993 Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75: 253–261
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W . 1993 Interleukin-10-deficient mice develop chronic enterocolitis Cell 75: 263–274
Loranger A, Duclos S, Grenier A, Price J, Wilson-Heiner M, Baribault H, Marceau N . 1997 Simple epithelium keratins are required for maintenance of hepatocyte integrity Amer. J. Pathol. 151: 1673–1683
Zatloukal K, Stumptner C, Lehner M, Denk H, Baribault H, Eshkind LG, Franke WW . 2000 Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies Am. J. Pathol. 156: 1263–1274
Ku N-O, Michie S, Soetikno R, Resurreccion E, Oshima RG, Omary MB . 1996 Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant J. Clin. Invest. 98: 1034–1046
Toivola DM, Omary MB, Ku N-O, Peltola O, Baribault H, Eriksson JE . 1998 Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity Hepatology 28: 116–128
Ku N-O, Michie S, Oshima RG, Omary MB . 1995 Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant J Cell Biol 131: 1303–1314
Omary MB, Ku NO . 1997 Intermediate filament proteins of the liver: emerging disease association and functions Hepatology 25: 1043–1048
Ku NO, Gish R, Wright TL, Omary MB . 2001 Keratin 8 mutations in patients with cryptogenic liver disease New Eng. J. Med. 344: 1580–1587
Caulin C, Ware CF, Magin TM, Oshima RG . 2000 Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis J. Cell Biol. 149: 17–22
Tagawa Y-I, Kakuta S, Iwakura Y . 1998 Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis Euro. J. Immunol. 28: 4105–4113
Ksontini R, Colagiovanni DB, Josephs MD, Edwards III CK, Tannahil CL, Solorzano CC, Norman J, Denham W, Clare-Salzler M, MacKay SLD, Moldawer LL . 1998 Disparate roles for TNF-α and Fas ligand in Concanavalin A-induced hepatitis J. Immunol. 160: 4082–4089
Zhang H, Cook J, Nickel J, Yu R, Stecker K, Myers K, Dean NM . 2000 Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis Nat. Biotechnol. 18: 862–867
Rasmussen CA, Pace JL, Banerjee S, Phillips TA, Hunt JS . 1999 Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors Placenta 20: 213–222
Drake BL, Head JR . 1990 Murine trophoblast cells are not killed by tumor necrosis factor-α J. Reprod. Immunol. 17: 93–99
Gilbert S, Loranger A, Daigle N, Marceau N . 2001 Simple epithelium keratins 8 and 18 provide resistance to fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation J. Cell Biol. 154: 763–774
Yamada Y, Kirillova I, Peschon JJ, Fausto N . 1997 Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor Proc. Natl. Acad. Sci. USA 94: 1441–1446
Bauman PA, Dalton WS, Anderson JM, Cress AE . 1994 Expression of cytokeratin confers multiple drug resistance Proc. Natl. Acad. Sci. USA 91: 5311–5314
Anderson JM, Heindl LM, Bauman PA, Ludi CW, Dalton WS, Cress AE . 1996 Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents Clin. Cancer Res. 2: 97–105
Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer PH . 1998 p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs J. Exp. Med. 188: 2033–2045
Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT . 2001 Anticancer agents sensitize tumor cells to tumor necrosis factor- related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis Cancer Res. 61: 1645–1651
Kaufmann SH, Earnshaw WC . 2000 Induction of apoptosis by cancer chemotherapy Exp. Cell Res. 256: 42–49
Liao J, Lowthert LA, Ghori N, Omary MB . 1995 The 70-kDa heat shock proteins associated with glandular intermediate filaments in an ATP-dependent manner J. Biol. Chem. 270: 915–922
Toivola DM, Baribault H, Magin T, Michie SA, Omary MB . 2000 Simple epithelial keratins are dispensable for cytoprotection in two pancreatitis models Am. J. Physiol. Gastrointest. Liver Physiol. 279: G1343–1354
Denham W, Yang J, Fink G, Denham D, Carter G, Ward K, Norman J . 1997 Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis Gastroenterology 113: 1741–1746
Ameen NA, Figueroa Y, Salas PJ . 2001 Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia J. Cell Sci. 114: 563–575
Faigle W, Colucci-Guyon E, Louvard D, Amigorena S, Galli T . 2000 Vimentin filaments in fibroblasts are a reservoir for SNAP23, a component of the membrane fusion machinery Mol. Biol. Cell 11: 3485–3494
Goldman RD, Chou Y-H, Prahlad V, Yoon M . 1999 Intermediate filaments: dynamic processes regulating their assembly, motility, and interactions with other cytoskeletal systems FASEB J. 13: 261–265
Neznanov N, Kondratova A, Chumakov KM, Angres B, Zhumabayeva B, Agol V, Gudkov A . 2001 Poliovirus protein 3A inhibits TNF-induced apoptosis by eliminating TNF receptor from the cell surface J. Virol. 75: 10409–10420
Liao J, Omary MB . 1996 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor J. Cell Biol. 133: 345–357
Ku N-O, Liao J, Chou C-F, Omary MB . 1996 Implications of intermediate filament protein phosphorylation Cancer Metastasis Rev. 15: 429–444
Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu Lee YH, Durkop H, Engelmann H, Scheurich P, Wajant H, Strasser A . 1999 Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF EMBO J. 18: 3034–3043
Inada H, Izawa I, Nishizawa M, Fujita E, Kiyono T, Takahashi T, Momoi T, Inagaki M . 2001 Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD J. Cell Biol. 155: 415–425
Weber K, Osborn M, Moll R, Wiklund B, Luning B . 1984 Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 18 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker EMBO J. 3: 2707–2714
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R . 1982 The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells Cell 31: 11–24
Caulin C, Salvesen GS, Oshima RG . 1997 Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial apoptosis J. Cell Biol. 138: 1379–1394
Ku N-O, Liao J, Omary MB . 1997 Apoptosis generates stable fragments of human type I keratins J. Biol. Chem. 272: 33197–33203
Stegh AH, Herrmann H, Lampel S, Weisenberger D, Andra K, Seper M, Wiche G, Krammer PH, Peter ME . 2000 Identification of the cytolinker Plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis Mol. Cell Biol. 20: 5665–5679
Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, Jornvall H, Schutte B . 1999 Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis J. Pathol. 187: 567–572
Ku NO, Omary MB . 2001 Effect of mutation and phosphorylation of type 1 keratins on their caspase-mediated degradation J. Biol. Chem. 276: 26792–26798
Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD . 1996 Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis Proc. Natl. Acad. Sci. USA 93: 8395–8400
Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC . 1995 Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptosis execution Proc. Natl. Acad. Sci. USA 92: 9042–9046
Prasad S, Soldatenkov VA, Srinivasarao G, Dritschilo A . 1999 Intermediate filament proteins during carcinogenesis and apoptosis International J. Oncol. 14: 564–570
Byun Y, Chen F, Chang R, Trived M, Green KJ, Cryns VL . 2001 Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis Cell Death Differ. 8: 443–450
Franke WW, Schmid E, Grund C . 1982 Intermediate filament proteins in nonfilamentous structures: transient disintegration and inclusion of subunit proteins in granular aggregates Cell 30: 103–113
MacFarlane M, Merrison W, Dinsdale D, Cohen GM . 2000 Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis J. Cell Biol. 148: 1239–1254
Ku N-O, Omary MB . 1994 Identification of the major physiologic phosphorylation site of human keratin 19: potential kinases and a role in filament reorganization J. Cell Biol. 127: 161–171
Muller K, Dulku S, Hardwick SJ, Skepper JN, Mitchinson MJ . 2001 Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein Atherosclerosis 156: 133–144
Eckes B, Colucci-Guyon E, Smola H, Nodder S, Babinet C, Krieg T, Martin P . 2000 Impaired wound healing in embryonic and adult mice lacking vimentin J. Cell Sci. 113: 2455–2462
Colucci-Guyon E, Portier M-M, Dunia I, Paulin D, Pournin S, Babinet C . 1994 Mice lacking veimentin develop and reproduce without an obvious phenotype Cell 79: 679–694
I am grateful to Normal Marceau for communicating recent results before publication and to Bishr Omary, Pierre Coulombe and Helene Baribault for helpful discussion. This work was supported by a grant from the National Cancer Institute (CA 42302).
Edited by M Piacentini
About this article
Cite this article
Oshima, R. Apoptosis and keratin intermediate filaments. Cell Death Differ 9, 486–492 (2002). https://doi.org/10.1038/sj.cdd.4400988
- intermediate filament
This article is cited by
The apoptotic effects of soybean agglutinin were induced through three different signal pathways by down-regulating cytoskeleton proteins in IPEC-J2 cells
Scientific Reports (2023)
Communications Biology (2022)
Molecular portrait of squamous cell carcinoma of the bovine horn evaluated by high-throughput targeted exome sequencing: a preliminary report
BMC Veterinary Research (2020)
Molecular manipulation of keratin 8/18 intermediate filaments: modulators of FAS-mediated death signaling in human ovarian granulosa tumor cells
Journal of Ovarian Research (2016)
Nature Communications (2015)